Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease. [PDF]
Toffoli M +18 more
europepmc +1 more source
Mucoactive Agents in Muco-Obstructive Lung Diseases: A Critical Reappraisal of Pharmacological Effects and Clinical Outcomes. [PDF]
Larobina D +15 more
europepmc +1 more source
Efficacy and safety of inhaled ambroxol solution in improving sputum of lower respiratory tract infection in children: a multicenter, randomized, double-blind, placebo-controlled trial. [PDF]
Xu B +9 more
europepmc +1 more source
N-acetylcysteine in paediatrics: a review of efficacy, safety and dosing strategies in respiratory care. [PDF]
Benedetti F, Santus P.
europepmc +1 more source
Meta-analysis of the adjuvant treatment of COPD with Erchen Decoction. [PDF]
Gao X, Lv X, Dong W, Zhang L, Zuo J.
europepmc +1 more source
Modest improvement of metabolic and behavioral deficits with long-term ambroxol treatment in a Pink1<sup>-/-</sup>SNCA<sup>A53T</sup> double mutant mouse model of Parkinson's disease. [PDF]
Franck L +10 more
europepmc +1 more source
Solid‐state density functional theory was utilized to determine the crystalline structure and analyze terahertz spectra of Ambroxol hydrochloride, a widely used drug. The vibration mode for each spectral feature has been described in terms of complex inter‐ and intramolecular movements.
Jan Rohlicek +2 more
exaly +2 more sources
Related searches:

